InvestorsHub Logo
Followers 18
Posts 932
Boards Moderated 0
Alias Born 04/26/2016

Re: Maciste post# 8453

Friday, 05/24/2019 4:52:45 PM

Friday, May 24, 2019 4:52:45 PM

Post# of 17397
Assuming the BO includes full rights to VOS...

I'd be happy with $30/sh on Monday, $40/sh after Ph3 data release, $50/sh after FDA approval. There's no model behind that, just what I'd be happy with right now. Let's call it 100m outstanding shares fully diluted at $50/sh puts the BO at $5b. With everything we now know, that doesn't seem like a stretch to me. Big question is whether the future acquirer will want to see adoption first. If so, price goes up...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News